2007•China Modern DoctorRequires access

Influence on Telmisartan on Restraining Atherosclerosis and Its Efficacy to Control Hypertension

Jun Wan

Open publisher page 0 citations

Abstract

Objective To observe the efficacy of telmisartan on restraining atherosclerosis and its way to control hypertension. Methods The patients with EH(n=45) were treated with telmisartan 40mg, po, qd, for 31w. The patients with EH(n=43) were treated with Felodipine 5mg, po, qd, for 31w. Use color duplex sonography for evaluating extracoranial. Results The intima-media thickness, the delection rate of atherosclerosis plaque, and the incidence of carotid artery stenosis in CI group were significantly different from controls (P 0.01) .At the end of 1w, BP decreased significantly in patients with EH treated with telmisartan(P 0.01) , BP decreased continuously up to 31w. The total hypotensive rate of valsartan was 57% at 1w and 93% at 31w repectively. Conclusion Telmisartan has significant control on hypertension, restraining vascular endothelial function unusually and the reflection of membrane hyperplasia, protects vascular endothelium, improves reconstruction of vascular and restrains atherosclerosis.

About this research paper

What this paper is about

Objective To observe the efficacy of telmisartan on restraining atherosclerosis and its way to control hypertension. Methods The patients with EH(n=45) were treated with telmisartan 40mg, po, qd, for 31w. The patients with EH(n=43) were treated with Felodipine 5mg, po, qd, for 31w. Use color duplex sonography for evaluating extracoranial. Results The intima-media thickness, the delection rate of atherosclerosis plaque, and the incidence of carotid artery stenosis in CI group were significantly different from controls (P 0.01) .At the end of 1w, BP decreased significantly in patients with EH treated with telmisartan(P 0.01) , BP decreased continuously up to 31w. The total hypotensive rate of valsartan was 57% at 1w and 93% at 31w repectively. Conclusion Telmisartan has significant control on hypertension, restraining vascular endothelial function unusually and the reflection of membrane hyperplasia, protects vascular endothelium, improves reconstruction of vascular and restrains atherosclerosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the efficacy of telmisartan on restraining atherosclerosis and its way to control hypertension. Methods The patients with EH(n=45) were treated with telmisartan 40mg, po, qd, for 31w. The patients with EH(n=43) were treated with Felodipine 5mg, po, qd, for 31w. Use color duplex sonography for evaluating extracoranial. Results The intima-media thickness, the delection rate of atherosclerosis plaque, and the incidence of carotid artery stenosis in CI group were significantly different from controls (P 0.01) .At the end of 1w, BP decreased significantly in patients with EH treated with telmisartan(P 0.01) , BP decreased continuously up to 31w. The total hypotensive rate of valsartan was 57% at 1w and 93% at 31w repectively. Conclusion Telmisartan has significant control on hypertension, restraining vascular endothelial function unusually and the reflection of membrane hyperplasia, protects vascular endothelium, improves reconstruction of vascular and restrains atherosclerosis.

Key concepts: Telmisartan, Medicine, Cardiology, Internal medicine, Valsartan, Endothelium, Urology, Felodipine

Related papers

Back to paper searchBrowse research topicsOriginal source
Influence on Telmisartan on Restraining Atherosclerosis and Its Efficacy to Control Hypertension — Research Paper | ScholarLens